CCIA
NPSP

Campbell & Co Investment Adviser’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Campbell & Co Investment Adviser’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-15,167
Closed -$229K – 433
2013
Q2 		$229K Buy
+15,167
New +$210K 0.04% 278

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Campbell & Co Investment Adviser's NPSP Position: Q3 2013 in Review

Campbell & Co Investment Adviser sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2013, closing a stake of 15,167 shares — an estimated $229K sold.

Campbell & Co Investment Adviser first reported a position in NPSP in Q2 2013 and held it in 1 quarter. The position peaked at $229K in Q2 2013. 182 funds tracked by Wall St. Rank hold NPSP as of Q3 2013.

  • Campbell & Co Investment Adviser reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 15,167 NPS PHARMACEUTICALS INC shares in Q3 2013, an estimated $229K.
  • Campbell & Co Investment Adviser first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's NPS PHARMACEUTICALS INC position peaked at $229K in Q2 2013.
  • 182 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2013.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2013, filed 6 Nov 2013.